The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate ...
FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.
Clinicians divided amid growing demand for leucovorin autism drug as major medical groups advise caution over safety and efficacy.
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...
Although FDA Commissioner Marty Makary promised “an exciting treatment” for autism, what the agency delivered was a label expansion for leucovorin to treat the ultrarare cerebral folate deficiency.
Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients. The study ...
Prenatal care is essential for the health of expectant mothers and newborns alike. The U.S. Department of Health & Human Services Office on Women's Health notes that babies of mothers who don't get ...
About 10% of patients who come to complex care hospitals may have low levels of folate and other indicators of malnutrition, investigators say. To ensure those patients are identified and helped, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results